Trials / Completed
CompletedNCT03371342
Treatment of MEDITOXIN® in Female Patients With Idiopathic Overactive Bladder
A Randomized, Double-blind, Active Controlled, Multi-center, Phase 1 Study to Investigate the Safety of MEDITOXIN® in Female Subjects With Idiopathic Overactive Bladder
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Medy-Tox · Industry
- Sex
- Female
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the safety of MEDITOXIN in female subjects with idiopathic overactive bladder compared with BOTOX
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Meditoxin | Meditoxin (Botulinum toxin type A) |
| DRUG | Botox | Botox(Botulinum toxin type A) |
Timeline
- Start date
- 2017-12-13
- Primary completion
- 2018-05-31
- Completion
- 2018-09-05
- First posted
- 2017-12-13
- Last updated
- 2019-03-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03371342. Inclusion in this directory is not an endorsement.